FAIRFAX, Va., Sept. 29, 2023 /PRNewswire/ — The National Institutes of Health’s National Cancer Institute (NCI) recently selected global consulting and digital services provider ICF (NASDAQ:ICFI) as one of three awardees for a new multiple-award indefinite delivery, indefinite quantity (IDIQ) contract to…
PALO ALTO, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) — Bitcoin Latinum (LTNM), the next generation, insured, asset-backed cryptocurrency, is announcing it will list on DigiFinex, one of the world’s largest cryptocurrency exchanges, in the third week of October. Monsoon Blockchain,…
Solutions 30 SE has released its interim report for the six months ended 30 June 2023. The report is available on Solution 30’s website (www.solutions30.com), in the Investors’ section, under Publications / Financial Reports. About Solutions 30 SE The Solutions 30 group…
LONDON, Sept. 29, 2023 (GLOBE NEWSWIRE) — According to The Business Research Company’s research report on the machinery leasing market, the global machinery leasing market size is expected to grow from $316.22 billion in 2020 to $342.66 billion in 2023…
WINSTON-SALEM, N.C. and HOUSTON, Sept. 29, 2023 /PRNewswire/ — DoorPro Systems, (“DoorPro”), Houston’s premier supplier of architectural doors, frames, hardware and specialty products including electronic access control, has announced the launch of their new company website and e-commerce portal at…
An Emerging Markets Sponsored Commentary ORLANDO, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) — Former American Poet Laureate, the late great Maya Angelou famously once said, “when someone shows you who they are, believe them…” The phrase is often used in…
TORONTO, 29 sept. 2023 (GLOBE NEWSWIRE) — Bénéfice dilué par action de 0,21 $ Ventes brutes de fonds communs de placement se chiffrant à 790 millions $ pour le troisième trimestre de 2023, soit une amélioration de 61 % sur douze mois Ventes nettes…
London, Sept. 29, 2023 (GLOBE NEWSWIRE) — Roots Analysis has announced the addition of “Biospecimen Contract Research Services Market, 2023 – 2030” report to its list of offerings. Given the growing number of research and development initiatives in the pharmaceutical…
DUBLIN, Sept. 29, 2023 /PRNewswire/ — AiPharma Global Holdings LLC (“AiPharma“), a private biopharmaceutical research, development, and commercialization company, and Appili Therapeutics Inc. (TSX: APLI;OTCQX: APLIF) (“Appili“), a biopharmaceutical company focused on drug development for infectious diseases, announced today a strategic…
Option exercise triggers upfront payment of approximately $150 million to Caelum shareholders, of which approximately $64 million is payable to Fortress Biotech1 AstraZeneca intends to advance and accelerate the Phase 3 development of CAEL-101 for light chain (AL) amyloidosis HSR…
